Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Healthcare Innovation Watch: The Next Milestones Investors Need to Track at RUA Life Sciences plc (RUA)

• Investors should prioritise operating delivery, cash flow, funding needs and the next company-confirmed milestone.

Ankur Sharma | 30 October 2026

Healthcare Innovation Watch: The Next Milestones Investors Need to Track at Kromek Group plc (KMK)

• Investors should prioritise operating delivery, cash flow, funding needs and the next company-confirmed milestone.

Ankur Sharma | 30 October 2026

Healthcare Innovation Watch: The Next Milestones Investors Need to Track at ImmuPharma plc (IMM)

• Investors should prioritise operating delivery, cash flow, funding needs and the next company-confirmed milestone.

Ankur Sharma | 30 October 2026

Healthcare Innovation Watch: The Next Milestones Investors Need to Track at Hemogenyx Pharmaceuticals plc (HEMO)

• Investors should prioritise operating delivery, cash flow, funding needs and the next company-confirmed milestone.

Ankur Sharma | 30 October 2026

FTSE 100 Spotlight: Why Convatec Group Plc (LSE:CTEC) Is Drawing Investor Attention on 30 October 2026

• The company operates through medical products and care solutions, with execution quality central to its investment case.

Ankur Sharma | 30 October 2026

Feedback (LSE:FDBK): AIM Stock in Focus as Business Update Reshapes Investor Questions

Feedback (LSE:FDBK) drew attention following its 29 October 2026 announcement concerning business update.

Ankur Sharma | 30 October 2026

FTSE 100 Spotlight: Why GSK plc (LSE:GSK) Is Drawing Investor Attention on 30 October 2026

• The company operates through vaccines and specialty medicines, with execution quality central to its investment case.

Ankur Sharma | 30 October 2026

HUTCHMED (LSE:HCM): AIM Stock in Focus as Us Orphan-Drug Designation For Sovleplenib Reshapes Investor Questions

HUTCHMED (LSE:HCM) drew attention following its 29 October 2026 announcement concerning US orphan-drug designation for sovleplenib.

Ankur Sharma | 30 October 2026

Haleon (LSE:HLN): FTSE 100 Stock in Focus as Third-Quarter Trading Statement And Gbp 500 Million Buyback Reshapes Investor Questions

Haleon (LSE:HLN) drew attention following its 29 October 2026 announcement concerning third-quarter trading statement and GBP 500 million buyback.

Ankur Sharma | 30 October 2026

Haleon PLC (LSE:HLN): Why This FTSE 100 Stock Is Drawing Investor Attention on 30 October 2026

Haleon PLC (LSE:HLN) is being assessed against consumer health volumes, brand pricing and portfolio performance.

Ankur Sharma | 30 October 2026
Support

Hi! How can we help you today?

Loading…